91 related articles for article (PubMed ID: 17290188)
1. In vivo imaging in a murine model of glioblastoma.
Jost SC; Wanebo JE; Song SK; Chicoine MR; Rich KM; Woolsey TA; Lewis JS; Mach RH; Xu J; Garbow JR
Neurosurgery; 2007 Feb; 60(2):360-70; discussion 370-1. PubMed ID: 17290188
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS
Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491
[TBL] [Abstract][Full Text] [Related]
3. 18F-FET microPET and microMRI for anti-VEGF and anti-PlGF response assessment in an orthotopic murine model of human glioblastoma.
Nedergaard MK; Michaelsen SR; Urup T; Broholm H; El Ali H; Poulsen HS; Stockhausen MT; Kjaer A; Lassen U
PLoS One; 2015; 10(2):e0115315. PubMed ID: 25680186
[TBL] [Abstract][Full Text] [Related]
4. MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation.
Park SS; Chunta JL; Robertson JM; Martinez AA; Oliver Wong CY; Amin M; Wilson GD; Marples B
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):885-92. PubMed ID: 21489704
[TBL] [Abstract][Full Text] [Related]
5. EphA2 as a Diagnostic Imaging Target in Glioblastoma: A Positron Emission Tomography/Magnetic Resonance Imaging Study.
Puttick S; Stringer BW; Day BW; Bruce ZC; Ensbey KS; Mardon K; Cowin GJ; Thurecht KJ; Whittaker AK; Fay M; Boyd AW; Rose S
Mol Imaging; 2015; 14():385-99. PubMed ID: 26218510
[TBL] [Abstract][Full Text] [Related]
6. Gliomas in rodent whisker barrel cortex: a new tumor model.
Sherburn EW; Wanebo JE; Kim P; Song SK; Chicoine MR; Woolsey TA
J Neurosurg; 1999 Nov; 91(5):814-21. PubMed ID: 10541239
[TBL] [Abstract][Full Text] [Related]
7. In vivo preclinical low-field MRI monitoring of tumor growth following a suicide-gene therapy in an orthotopic mice model of human glioblastoma.
Breton E; Goetz C; Kintz J; Accart N; Aubertin G; Grellier B; Erbs P; Rooke R; Constantinesco A; Choquet P
C R Biol; 2010 Mar; 333(3):220-5. PubMed ID: 20338540
[TBL] [Abstract][Full Text] [Related]
8. [Use of the functional imaging modalities in radiation therapy treatment planning in patients with glioblastoma].
Dhermain F; Ducreux D; Bidault F; Bruna A; Parker F; Roujeau T; Beaudre A; Armand JP; Haie-Meder C
Bull Cancer; 2005 Apr; 92(4):333-42. PubMed ID: 15888390
[TBL] [Abstract][Full Text] [Related]
9. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
Slagel DE; Feola J; Houchens DP; Ovejera AA
Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
[TBL] [Abstract][Full Text] [Related]
10. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.
Veeravagu A; Hou LC; Hsu AR; Cai W; Greve JM; Chen X; Tse V
Neurol Res; 2008 Nov; 30(9):952-9. PubMed ID: 18662497
[TBL] [Abstract][Full Text] [Related]
11. Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel.
Hsu AR; Cai W; Veeravagu A; Mohamedali KA; Chen K; Kim S; Vogel H; Hou LC; Tse V; Rosenblum MG; Chen X
J Nucl Med; 2007 Mar; 48(3):445-54. PubMed ID: 17332623
[TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment.
Liu HL; Hua MY; Chen PY; Chu PC; Pan CH; Yang HW; Huang CY; Wang JJ; Yen TC; Wei KC
Radiology; 2010 May; 255(2):415-25. PubMed ID: 20413754
[TBL] [Abstract][Full Text] [Related]
13. Predicting and monitoring response to chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea in subcutaneously implanted 9L glioma using the apparent diffusion coefficient of water and 23Na MRI.
Babsky AM; Hekmatyar SK; Zhang H; Solomon JL; Bansal N
J Magn Reson Imaging; 2006 Jul; 24(1):132-9. PubMed ID: 16758478
[TBL] [Abstract][Full Text] [Related]
14. Growth kinetics and treatment response of the intracerebral rat 9L brain tumor model: a quantitative in vivo study using magnetic resonance imaging.
Kim B; Chenevert TL; Ross BD
Clin Cancer Res; 1995 Jun; 1(6):643-50. PubMed ID: 9816027
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of treatment-associated inflammatory response on diffusion-weighted magnetic resonance imaging and 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography imaging biomarkers.
Galbán CJ; Bhojani MS; Lee KC; Meyer CR; Van Dort ME; Kuszpit KK; Koeppe RA; Ranga R; Moffat BA; Johnson TD; Chenevert TL; Rehemtulla A; Ross BD
Clin Cancer Res; 2010 Mar; 16(5):1542-52. PubMed ID: 20160061
[TBL] [Abstract][Full Text] [Related]
16. Concurrent treatment with BCNU and Gamma Knife radiosurgery in the rat malignant glioma model.
Cho KT; Kim DG; Paek SH; Chung HT; Jung HW; Park HW
J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):132-41. PubMed ID: 22628080
[TBL] [Abstract][Full Text] [Related]
17. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
Cai L; Gao S; Li DC; Li YS; Chen QS; Xing XL
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):134-8. PubMed ID: 19538892
[TBL] [Abstract][Full Text] [Related]
18. Experimental study on the therapeutic effect of positron emission tomography agent [¹⁸F]-labeled 2-deoxy-2-fluoro-d-glucose in a colon cancer mouse model.
Fang S; Wang J; Jiang H; Zhang Y; Xi W; Zhao C; Tian M; Zhang H
Cancer Biother Radiopharm; 2010 Dec; 25(6):733-40. PubMed ID: 21204768
[TBL] [Abstract][Full Text] [Related]
19. Conversion of arterial input functions for dual pharmacokinetic modeling using Gd-DTPA/MRI and 18F-FDG/PET.
Poulin E; Lebel R; Croteau E; Blanchette M; Tremblay L; Lecomte R; Bentourkia M; Lepage M
Magn Reson Med; 2013 Mar; 69(3):781-92. PubMed ID: 22570280
[TBL] [Abstract][Full Text] [Related]
20. Preclinical efficacy of the anti-hepatocyte growth factor antibody ficlatuzumab in a mouse brain orthotopic glioma model evaluated by bioluminescence, PET, and MRI.
Mittra ES; Fan-Minogue H; Lin FI; Karamchandani J; Sriram V; Han M; Gambhir SS
Clin Cancer Res; 2013 Oct; 19(20):5711-21. PubMed ID: 23983258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]